Biopharma's R&D leaders on how technology can accelerate drug development

How emerging digital tools are providing enhanced clinical insights and improved trial results.

By Taren Grom • Jan. 27, 2022

How AI is helping pharma solve some of its COVID problems

With the pressure still on pharma to innovate quickly and go digital, the use-cases for AI are increasing in stride.

By Meagan Parrish • Jan. 25, 2022

Explore the Trendline➔

Commercialization, marketing and social media

As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

By PharmaVoice staff

One man's quest to boost the patient's role in clinical trials

How a personal diagnosis inspired Craig Lipset to transform patient involvement in medical research.

By Robin Robinson • Jan. 24, 2022

Leaders predict improving patient engagement will lead to growth opportunities

Why patient engagement is key to successful business growth.

By Taren Grom • Jan. 24, 2022

Evofem CEO Saundra Pelletier aims to level the playing field between men's and women's health

Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women's health.

By Alexandra Pecci • Jan. 23, 2022

Vaxxinity looks to pioneer the next revolution in pharma

With a one-of-a-kind platform and novel candidates for major indications, Vaxxinity wants to disrupt the industry’s paradigm of success. 

By Meagan Parrish • Jan. 14, 2022

Pharma execs reveal the industry's most pressing issues

Several market factors — including COVID — are driving changes and trends in the industry.

By Taren Grom • Jan. 14, 2022

Pharma M&A stagnated in 2021 — here's what could help it rebound

There are plenty of reasons pharma could get its M&A groove back in 2022.

By Meagan Parrish • Jan. 13, 2022

Welcome to the new PharmaVoice

A similar mission, a new format, and our plans for PharmaVoice's next chapter.

By Davide Savenije • Jan. 13, 2022

Biote CEO breaks down barriers in women's health

Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.

By Robin Robinson • Jan. 11, 2022

Ovid's CEO shares his vision for rare disease developments

Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

By Kim Ribbink • Jan. 10, 2022

How the executive VP of HR at Incyte is tackling pharma's hiring woes

In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.

By Meagan Parrish • Jan. 10, 2022

Australian firefighters raise funds for ALS research

Funding for rare disease clinical trials can be a challenge, but in Australia, firefighters gear up to raise money for ALS. 

By Kim Ribbink • Jan. 5, 2022

Rare disease innovation in 2022

More companies are targeting gene therapies for rare disease treatments.

By Kim Ribbink • Jan. 5, 2022

PharmaVoice 100 Who's on the List – By Category

Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...

By PharmaVoice Team • Aug. 1, 2021

Entrepreneurs

These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights. Do you have CLAS? (Culturally and Linguistically Appropriate Strategies) Igniting change by… Having courageous conversations about race, ethnicity...

By PharmaVoice Team • Aug. 1, 2021

Change Agents

These forward-thinking individuals are disrupting the status quo and setting the strategic direction for their companies to capitalize on the opportunities that will shape the future of the healthcare ecosystem. Put people first, the rest will follow Sparking innovation by… collabor...

By PharmaVoice Team • Aug. 1, 2021

2021 Red Jacket Honorees

Inspiring leaders for today and tomorrow Since launching the Red Jacket Award in 2014, PharmaVOICE has recognized 40 inspiring, innovative, collaborative, and transformative individuals who epitomize leadership for today and tomorrow. One of the criteria for being named a Red Jacket — our version...

By PharmaVoice Team • Aug. 1, 2021

Red Jacket Ahsan Awan

A man of many talents Sparking innovation by… creating a world that works for everyone Ahsan A. Awan Title: VP of Clinical Development Company: Genlantis Diagnostics Education: J.D., University of Oregon School of Law; M.S.Pharm., Pharmacy, Pharmacoeconomics, University of Florid...

By Ahsan Awan • Aug. 1, 2021

Red Jacket Jack Barrette

Giving a voice to patient advocates Sparking innovation by… powering human connections for a healthier world Jack Barrette Title: Chief Innovation Officer, Health Union (formerly Founder & CEO of WEGO Health) Company: Health Union Education: B.A., English Industry Awards: Ph...

By Jack Barrette • Aug. 1, 2021

Red Jacket Olivier Chateau

Redefining social health Blazing new trails by… innovating online communities Olivier Chateau Title: Co-Founder and CEO Company: Health Union Industry Awards: PharmaVOICE 100, 2018, 2009; EY Entrepreneur of the Year Award, 2020 Company Awards: Inc.’s Best Workplaces; Forbe...

By Olivier Chateau • Aug. 1, 2021

Red Jacket Laurie Cooke

A leader of leaders Blazing new trails by… advancing gender parity and equity Laurie Cooke, RPh Title: President and CEO Company: Healthcare Businesswomen’s Association Education: PG Dip, Software Engineering Management, University of Luton; Advanced Degree, Pharmacy, Unive...

By Laurie Cooke • Aug. 1, 2021

Red Jacket Debbie Hart

The great biotech convener Sparking innovation by… convening companies across the N.J. life-sciences ecosystem Debbie Hart Title: President and CEO Company: BioNJ Education: M.S., cum laude, S. I. Newhouse School at Syracuse University; B.A., magnum cum laude, Trenton State Colle...

By Debbie Hart • Aug. 1, 2021

Red Jacket Dr. Antony Loebel

Bringing innovation to patients with serious CNS conditions Sparking innovation by… Transforming the discovery and development of central nervous system treatments Antony Loebel, M.D. Title: President and CEO Company: Sunovion Pharmaceuticals Inc. Education: B.A., University of W...

By Antony Loebel • Aug. 1, 2021

Red Jacket Steven Michaelson

Making magic happen Sparking innovation by… creating opportunities for talent to flourish Steven Michaelson Title: Founder and CEO Company: Calcium Education: BFA, Pratt Institute Industry Awards: 2021, The Pinnacle Award; Winner, MM&M, 2019 Industry Person of the Year; MedA...

By Steven Michaelson • Aug. 1, 2021